Breaking News
Get 40% Off 0
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks. Unlock full list
Close

Prime Medicine Inc (PRME)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Prime Medicine's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
7.510 +0.430    +6.07%
- Real-time Cboe. Currency in USD ( Disclaimer )
  • Volume: 616,103
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 6.910 - 7.630
Type:  Equity
Market:  United States
Prime Medicine 7.510 +0.430 +6.07%

Prime Medicine Company Profile

 
Read the Prime Medicine Inc company profile to learn more about the business and the management team. View Prime Medicine Inc facts about employee data, company products and services, and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

234

Equity Type

ORD

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address the spectrum of diseases by deploying gene editing technology. The company offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. It has a research collaboration with Cimeio Therapeutics to develop Prime Edited Shielded-Cell & Immunotherapy Pairs for genetic diseases, acute myeloid leukemia, and myelodysplastic syndrome. The company was incorporated in 2019 and is based in Cambridge, Massachusetts.

Contact Information

Address 21 Erie Street
Cambridge, 02139
United States
Phone 617 564 0013
Fax -

Top Executives

Name Age Since Title
Anastasia Khvovora 54 2022 Member of Scientific Advisory Board
Agnieszka Czechowicz - 2022 Member of Scientific Advisory Board
David R. Liu - 2022 Co-Founder & Chair of Scientific Advisory Board
Wendy K. Chung 54 2021 Independent Director
Robert Taylor Nelsen 61 2020 Independent Director
Yvonne Chen - 2022 Member of Scientific Advisory Board
Keith Michael Gottesdiener 69 2020 President, CEO, Secretary & Director
Eric N. Olson - - Member of Scientific Advisory Board
Kaye I. Foster-Cheek 63 2021 Independent Director
Guangping Gao - 2022 Member of Scientific Advisory Board
David P. Schenkein 66 2019 Independent Director
James Haber - 2022 Member of Scientific Advisory Board
Samuel H. Sternberg - 2022 Member of Scientific Advisory Board
Shengdar Q. Tsai - 2022 Member of Scientific Advisory Board
Jay Shendure - 2022 Member of Scientific Advisory Board
Michael A. Kelly 66 2021 Independent Director
Muthiah Manoharan 70 2022 Member of Scientific Advisory Board
Ben Kleinstiver - 2022 Member of Scientific Advisory Board
Thomas J. Cahill 36 2021 Independent Director
Jeffrey D. Marrazzo 44 2023 Director
Gerald Schwank - 2023 Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PRME Price Commentary

Write your thoughts about Prime Medicine Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email